Community Based Management of Diabetes in Nepal
COBIN-D
Community Based Intervention for Management of Diabetes in Nepal (COBIN-D): A Cluster Randomised Controlled Trial
1 other identifier
interventional
224
1 country
1
Brief Summary
Type 2 diabetes is the largest growing concern across the globe, and this is particularly apparent in developing countries, including Nepal. Despite the growing burden and chronic nature of diabetes, prevention and control of this disease is far from adequate setting in Nepal. Moreover, there is lack of evidence on effectiveness and affordability of a population approach on reducing blood glucose level among diabetes persons. The main aim of this study is to determine the effect of Female Community Health Volunteers' (FCHVs)-led family-based health education and screening on blood sugar level in adults at community level in Nepal. This is a community-based cluster randomized controlled trial involving family based health education through FCHVs in Nepal. People ≥25 years of age listed in the Community-Based Management of Hypertension (COBIN) study and who were diabetics are eligible for eligible for participation in the study. FCHVs will conduct family based health education and fasting blood glucose measurements in the treatment arm vs not any interventions in the control arm. Independent assessors will conduct the baseline and end line assessment of the intervention. Intention to treat analysis and per protocol analysis will be used in analysis to detect significant differences between treatment and control group participants at baseline and follow up. For individual outcomes, proportions will be compared using Chi-square test and continuous measures will be compared using t-tests. Random effect mixed regression analysis will be adjusted for age and sex. Since randomisation will be at the cluster level in the study, a random-effect model will be used to account for clustering effect. Effectiveness of the intervention will be tested by analysis of covariance, which will allow us to adjust for baseline differences between groups. It is anticipated that the study can give valuable information regarding effectiveness, acceptability, and feasibility of an innovative way to improve diabetes management. Assessing the FCHVs' ability to address diabetes may contribute to develop a policy that can be scaled-up to a national level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes-mellitus
Started Jun 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 3, 2017
CompletedFirst Posted
Study publicly available on registry
October 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2019
CompletedAugust 13, 2020
August 1, 2020
1.3 years
October 3, 2017
August 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean fasting blood glucose level
Change in mean fasting blood glucose level in diabetes populations
1 year
Study Arms (2)
FCHV visit-diabetes
EXPERIMENTALFCHV no visit-diabetes
NO INTERVENTIONInterventions
FCHVs will visit selected households 3 times a year for providing health promotion messages and measure the blood glucose
Eligibility Criteria
You may qualify if:
- Those ≥25 years of age and listed in the COBIN study
- Those who participated in our prevalence study
- Those who give consent to participate in our intervention study
- Those who do not have any plan to migrate from the study area for at least 1 year
- Those who are non-pregnant women
- Those who are not severely ill
You may not qualify if:
- Those who do not give consent
- Those who are pregnant women
- Those who are severely ill
- Those who have plans to migrate from the study area within 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
A semi-urban area of Pokhara-Lekhnath Metropolitan City of Nepal
Pokhara, Nepal
Related Publications (2)
Gyawali B, Sharma R, Mishra SR, Neupane D, Vaidya A, Sandbaek A, Kallestrup P. Effectiveness of a Female Community Health Volunteer-Delivered Intervention in Reducing Blood Glucose Among Adults With Type 2 Diabetes: An Open-Label, Cluster Randomized Clinical Trial. JAMA Netw Open. 2021 Feb 1;4(2):e2035799. doi: 10.1001/jamanetworkopen.2020.35799.
PMID: 33523189DERIVEDGyawali B, Neupane D, Vaidya A, Sandbaek A, Kallestrup P. Community-based intervention for management of diabetes in Nepal (COBIN-D trial): study protocol for a cluster-randomized controlled trial. Trials. 2018 Oct 22;19(1):579. doi: 10.1186/s13063-018-2954-3.
PMID: 30348188DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD scholar
Study Record Dates
First Submitted
October 3, 2017
First Posted
October 6, 2017
Study Start
June 1, 2017
Primary Completion
September 30, 2018
Study Completion
January 31, 2019
Last Updated
August 13, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share